The trajectory of Viagra presents a complex case for investors in the medicinal sector. While initially a blockbuster success, generating billions, the exclusivity end and the subsequent flood of generic competitors https://adult686295.acidblog.net/73050539/the-little-copyright-and-big-pharma-a-risky-bet